This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ARTHUR BIDDLE, M.D.; HAROLD KOENIG, M.D.

AMA Arch Intern Med. 1958;102(5):801-805.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

In 1950, Mosberg and Arnold reviewed all reported cases of cryptococcosis.¹ In summarizing results with more than 25 therapeutic agents, they concluded that "no methods of treatment have proved effective... any encouragement provided by an apparent response to a drug is in most cases nullified by an equally discouraging response when the same drug is employed on another patient."

In 1952, Carton² summarized the approximately 200 reported cases of cryptococcosis with central nervous system involvement with the statement that of the 14 patients alive at the time of their respective reports only 1 could be considered cured. (This patient was well and apparently free of infection six years after treatment with sulfadiazine.³) Carton then summarized the previously reported experiences with cycloheximide (Actidione, Upjohn), including seven fairly well documented cases, by saying "the use of Actidione in the central nervous system disease has been unsatisfactory, except for . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Department of Neurology and Psychiatry and the Department of Surgery, Northwestern University Medical School, and the Neuropsychiatric Service, Veterans' Administration Research Hospital.

Footnotes
Submitted for publication April 7, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?